C0026912||Mycobacterial
C1336776||Caseinolytic Protease Gene Regulator
C1336776||ClgR
C0052605||Caseinolytic Protease
C0026912||mycobacterial
C0052605||caseinolytic protease
C0052605||ClpP1P2
C0030940||degradative protease
C0013227||drug
C0041296||tuberculosis
C0052605||ClpP1P2
C0014432||inhibitor
C0086418||human
C1443643||proteasome inhibitor
C1176309||bortezomib
C0004611||bacterial
C1524081||inhibition
C0052605||ClpP1P2
C1149574||antimicrobial activity
C1336776||caseinolytic protease gene regulator
C1336776||ClgR
C1335528||clpP1P2 genes
C0040648||transcription factor
C0030940||protease
C0086860||promoter
C1176309||bortezomib
C0085957||Mycobacterium bovis BCG
C0040649||transcription
C1335528||clpP1P2
C1336776||ClgR
C0086860||promoters
C1524081||inhibition
C0052605||ClpP1P2
C0007634||cellular
C1336776||ClgR
C0960938||red fluorescent protein
C1336776||ClgR
C1293131||fusion
C0936012||analyses
C1336776||ClgR
C0052605||ClpP1P2
C1336776||ClgR's
C0030956||C-terminal nonapeptide APVVSLAVA
C0597304||protein degradation
C0052605||ClpP1P2
C4055506||accumulation
C1336776||ClgR
C0004587||bacilli
C3537153||mechanism
C1524081||inhibition
C0052605||ClpP1P2 protease
C0243102||activity
C1176309||bortezomib
C1149575||antibacterial activity
C1306577||deaths
C0041296||tuberculosis
C0026926||Mycobacterium tuberculosis
C0009450||infectious disease
C0013227||drugs
C0012634||disease
C0026912||mycobacterial
C0030940||protease
C0052605||ClpP1P2
C0086418||human
C0003392||anticancer drug
C1176309||bortezomib
C1171362||expression
C0052605||protease
C2755857||regulated
C0033684||proteins
C0004611||bacterium
C0597304||degrades
C0030940||protease
C0033684||proteins
C1524081||inhibition
C0052605||ClpP1P2
C1149574||antimicrobial activity
C0052605||ClpP1P2 protease
C2755857||regulates
C1171362||expression
C0002518||recognition sequence
C3537153||mechanism
C0052605||ClpP1P2
C1524081||inhibition
C0004611||bacterial
C2249823||growth inhibition